Cel Sci CVM
NYSE CVM
$1.78 +0.08 (+4.90%)
As of: Sep 29, 2026 · 3:58 PM EDT

Cel Sci (CVM) Asset Utilization Ratio (2017)

Updated

Cel Sci's (CVM) Asset Utilization Ratio came in at 0.01 for fiscal Q3 2017 (quarter ended Jun 30, 2017).

Analysis

Cel Sci (CVM) Asset Utilization Ratio (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.49
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.47
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.52
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.44
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.53
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 0.47
10 Cel Sci 3.11 Mn -22.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 0.01
API Access

Cel Sci Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CVM&period=max&api_key=YOUR_API_KEY